6-31670030-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBA1
The NM_021221.3(LY6G5B):c.-921C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.296 in 897,250 control chromosomes in the GnomAD database, including 42,643 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.37 ( 11200 hom., cov: 33)
Exomes 𝑓: 0.28 ( 31443 hom. )
Consequence
LY6G5B
NM_021221.3 5_prime_UTR
NM_021221.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.55
Genes affected
LY6G5B (HGNC:13931): (lymphocyte antigen 6 family member G5B) LY6G5B belongs to a cluster of leukocyte antigen-6 (LY6) genes located in the major histocompatibility complex (MHC) class III region on chromosome 6. Members of the LY6 superfamily typically contain 70 to 80 amino acids, including 8 to 10 cysteines. Most LY6 proteins are attached to the cell surface by a glycosylphosphatidylinositol (GPI) anchor that is directly involved in signal transduction (Mallya et al., 2002 [PubMed 12079290]).[supplied by OMIM, Mar 2008]
CSNK2B (HGNC:2460): (casein kinase 2 beta) This gene encodes the beta subunit of casein kinase II, a ubiquitous protein kinase which regulates metabolic pathways, signal transduction, transcription, translation, and replication. The enzyme is composed of three subunits, alpha, alpha prime and beta, which form a tetrameric holoenzyme. The alpha and alpha prime subunits are catalytic, while the beta subunit serves regulatory functions. The enzyme localizes to the endoplasmic reticulum and the Golgi apparatus. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 6-31670030-C-T is Benign according to our data. Variant chr6-31670030-C-T is described in ClinVar as [Benign]. Clinvar id is 1253018.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.52 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LY6G5B | NM_021221.3 | c.-921C>T | 5_prime_UTR_variant | 1/3 | ENST00000375864.5 | ||
CSNK2B | NM_001320.7 | c.*104C>T | 3_prime_UTR_variant | 7/7 | ENST00000375882.7 | ||
CSNK2B | NM_001282385.2 | c.*104C>T | 3_prime_UTR_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LY6G5B | ENST00000375864.5 | c.-921C>T | 5_prime_UTR_variant | 1/3 | 1 | NM_021221.3 | P1 | ||
CSNK2B | ENST00000375882.7 | c.*104C>T | 3_prime_UTR_variant | 7/7 | 1 | NM_001320.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.368 AC: 55883AN: 151944Hom.: 11188 Cov.: 33
GnomAD3 genomes
AF:
AC:
55883
AN:
151944
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.281 AC: 209349AN: 745188Hom.: 31443 Cov.: 10 AF XY: 0.279 AC XY: 105739AN XY: 379516
GnomAD4 exome
AF:
AC:
209349
AN:
745188
Hom.:
Cov.:
10
AF XY:
AC XY:
105739
AN XY:
379516
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.368 AC: 55937AN: 152062Hom.: 11200 Cov.: 33 AF XY: 0.375 AC XY: 27848AN XY: 74314
GnomAD4 genome
AF:
AC:
55937
AN:
152062
Hom.:
Cov.:
33
AF XY:
AC XY:
27848
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1228
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 11, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at